2012年更新

論文

●The role of transforming growth factor-α on mucin overproduction in eosinophilic chronic rhinosinusitis.Pharmacology. 2011;88(5-6):302-8. 2011
●Effects of clarithromycin and dexamethasone on mucus production in isografted rat trachea.Pharmacology. 2011;87(1-2):56-62. 2011
●Effects of a novel nonantibiotic macrolide, EM900, on cytokine and mucin gene expression in a human airway epithelial cell line.Pharmacology. 2011;88(5-6):327-32. 2011
●Remodeling of nasal mucosa by allergen exposure in guinea pigs is suppressed by steroid and pranlukast.Rhinology. 2009 Jun;47(2):199-206. 2009
●Remodeling of nasal mucosa by allergen exposure in guinea pigs is suppressed by steroid and pranlukast.Rhinology. 2009 Jun;47(2):199-206. 2009
●Synergistic induction of nuclear factor-kappaB by transforming growth factor-beta and tumour necrosis factor-alpha is mediated by protein kinase A-dependent RelA acetylation. Biochem J. 2009 Jan 15;417(2):583-91. 2009
●Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling.J Biol Chem. 2008 May 2;283(18):12546-54.　2008
●Leukotriene D4 upregulates MUC2 gene transcription in human epithelial cells.Pharmacology. 2008;81(3):221-8. 2008
●Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice.PLoS One. 2007 Oct 10;2(10):e1032. 2007
●Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity. 2007 Aug;27(2):349-60. 2007
●TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation. EMBO J. 2007 Feb 21;26(4):1150-62. 2007
●Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK.Biochem Biophys Res Commun. 2006 Dec 15;351(2):368-75. 2006
●The transforming growth factor-beta-Smad3/4 signaling pathway acts as a positive regulator for TLR2 induction by bacteria via a dual mechanism involving functional cooperation with NF-kappaB and MAPK phosphatase 1-dependent negative cross-talk with p38 MAPK.J Biol Chem. 2006 Aug 4;281(31):22397-408. 2006
●Malignant external otitis: treatment with prolonged usage of antibiotics and Burow's solution. Auris Nasus Larynx. 2005 Dec;32(4):403-6. 2006
●Pranlukast inhibits NF-kappaB activation and MUC2 gene expression in cultured human epithelial cells. Pharmacology, 73(2): 89-96. 2005
●Roxithromycin suppresses mucin gene expression in epithelial cells. Pharmacology. 2004 Sep;72(1):6-11. 2004
●High-pressure grease injury of the face. Am J Otolaryngol. 2004 Jul-Aug;25(4):278-81. 2004
●Long-term outcome of benign paroxysmal positional vertigo. Neurology. 2003 May 13;60(9):1532-4. 2003
●A case of bilateral cervical lymph node metastasis of thyroglossal duct cancer.
Auris Nasus Larynx. 2003 Feb;30(1):107-11. 2003
●Mucin gene expression in the effusions of otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2003 Jan;67(1):53-8. 2003
●Pendred’s syndrome with goiter and enlarged vestibular aqueducts diagnosed by PDS gene mutation. Head Neck, 24(7): 710-713. 2002
●Effects of dexamethasone on mucin gene expression in cultured human nasal epithelial cells. Laryngoscope, 112: 1436-1440. 2002
●Histamine alters gene expression in cultured human nasal epithelial cells. J Allergy Clin Immunol. 2001 Feb;107(2):310-4. 2001

関連ホームページ

• 三重大学大学院医学系研究科耳鼻咽喉･頭頸部外科学